Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Senti Biosciences Biotechnology Research, biotech, deeptech | Other 31 Jan 2025 | | |
 | Ulysse Communication Public Relations and Communications Services | Other 31 Jan 2025 | | |
 | Turenne Groupe Venture Capital and Private Equity Principals | Other 15 Feb 2025 | | |
 | La Direction fintech | Other 17 Feb 2025 | | |
 | IRIS Venture Capital and Private Equity Principals | Other 8 Apr 2025 | | |
 | MGA Technologies Industrial Machinery Manufacturing, manufacturing, industry 4.0 | Other 18 Feb 2025 | | |
 | In Extenso Innovation Croissance consulting | Other 9 Jun 2023 | | |
 | SISTA Civic and Social Organizations, fintech | Other 4 Feb 2025 | | |
 | Hopia Hospitals and Health Care, healthtech | Other 28 Jan 2025 | | |
 | Coave Therapeutics Biotechnology Research, healthtech, biotech, deeptech | Other 10 Jan 2025 | | |